Covered recipient · General Payments record
PEDRO ANTONIO ITURBIDE SILES
Allopathic & Osteopathic Physicians Orthopaedic Surgery Sports Medicine
General Payments · PY2021–2023
$7,911.24
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $879.04 | 3 |
| Food and Beverage | $320.80 | 15 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Arthrex, Inc. | $1,199.84 | 18 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Arthrex, Inc. | $10.00 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045962635 | CMS |
| Arthrex, Inc. | $10.00 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045962641 | CMS |
| Arthrex, Inc. | $10.00 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045962646 | CMS |
| Arthrex, Inc. | $10.00 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045962651 | CMS |
| Arthrex, Inc. | $10.00 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045962663 | CMS |
| Arthrex, Inc. | $10.00 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045962669 | CMS |
| Arthrex, Inc. | $10.00 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045962677 | CMS |
| Arthrex, Inc. | $24.00 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045962705 | CMS |
| Arthrex, Inc. | $60.00 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045962739 | CMS |
| Arthrex, Inc. | $10.00 | 01/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045962683 | CMS |
| Arthrex, Inc. | $10.00 | 01/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045962689 | CMS |
| Arthrex, Inc. | $10.00 | 01/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045962695 | CMS |
| Arthrex, Inc. | $24.00 | 01/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045962711 | CMS |
| Arthrex, Inc. | $78.46 | 01/30/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1045962719 | CMS |
| Arthrex, Inc. | $56.40 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045962725 | CMS |
| Arthrex, Inc. | $56.40 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045962733 | CMS |
| Arthrex, Inc. | $400.29 | 02/23/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1045962745 | CMS |
| Arthrex, Inc. | $400.29 | 02/23/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1045962753 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.